Regenerative Medical Technology (RMTG) Accumulated Expenses (2017 - 2026)

Regenerative Medical Technology's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $205152.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 98.2% year-over-year to $205152.0; the TTM figure through Mar 2026 stood at $205152.0 (down 98.2% YoY), while the FY2025 annual figure was $348394.0, down 96.68% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $205152.0, down from $348394.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $15.4 million in Q3 2025, with the low at $205152.0 in Q1 2026.
• The 5-year median for Accumulated Expenses is $6.6 million (2023), against an average of $6.8 million.
• The sharpest annual moves came in 2022 and 2026: Accumulated Expenses surged 118.73% in 2022, then sank 98.2% in 2026.
• Regenerative Medical Technology's Accumulated Expenses stood at $4.7 million in 2022, then soared by 41.65% to $6.6 million in 2023, then jumped by 59.23% to $10.5 million in 2024, then sank by 96.68% to $348394.0 in 2025, then plunged by 41.11% to $205152.0 in 2026.
• Business Quant data shows RMTG's Accumulated Expenses at $205152.0 in Q1 2026, $348394.0 in Q4 2025, and $15.4 million in Q3 2025.